|
CA1157858A
(en)
|
1979-12-03 |
1983-11-29 |
Ikuo Ueda |
Quinazoline derivatives
|
|
DE4407047A1
(de)
|
1994-03-03 |
1995-09-07 |
Merck Patent Gmbh |
Acetamide
|
|
DE19927415A1
(de)
|
1999-06-16 |
2000-12-21 |
Bayer Ag |
Indolinylharnstoffderivate
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
US6566372B1
(en)
|
1999-08-27 |
2003-05-20 |
Ligand Pharmaceuticals Incorporated |
Bicyclic androgen and progesterone receptor modulator compounds and methods
|
|
TW200303304A
(en)
|
2002-02-18 |
2003-09-01 |
Astrazeneca Ab |
Chemical compounds
|
|
US7009052B2
(en)
|
2003-03-20 |
2006-03-07 |
Warner Lambert Company Llc |
Sulfonamide derivatives
|
|
GB0322722D0
(en)
|
2003-09-27 |
2003-10-29 |
Glaxo Group Ltd |
Compounds
|
|
TWI332003B
(en)
|
2004-01-30 |
2010-10-21 |
Lilly Co Eli |
Kinase inhibitors
|
|
US20070049593A1
(en)
|
2004-02-24 |
2007-03-01 |
Japan Tobacco Inc. |
Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
|
|
PT1719773E
(pt)
|
2004-02-24 |
2009-06-03 |
Japan Tobacco Inc |
Compostos heterotetracíclicos fundidos e a sua utilização como inibidores da polimerase do hcv
|
|
EP1735306A2
(en)
|
2004-03-25 |
2006-12-27 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
|
|
WO2007014226A2
(en)
|
2005-07-26 |
2007-02-01 |
The Board Of Trustees Of The University Of Illinois |
Compounds for the treatment of neurodegeneration and stroke
|
|
CA2637933C
(en)
|
2006-01-24 |
2013-03-12 |
Eli Lilly And Company |
Indole sulfonamide modulators of progesterone receptors
|
|
CN101405001A
(zh)
|
2006-03-20 |
2009-04-08 |
霍夫曼-拉罗奇有限公司 |
抑制btk和syk蛋白质激酶的方法
|
|
US20100298289A1
(en)
|
2007-10-09 |
2010-11-25 |
Ucb Pharma, S.A. |
Heterobicyclic compounds as histamine h4-receptor antagonists
|
|
CN101903025A
(zh)
|
2007-10-19 |
2010-12-01 |
彼帕科学公司 |
利用苯并吡喃酮-型parp抑制剂治疗癌症的方法和组合物
|
|
KR20100122512A
(ko)
|
2008-07-17 |
2010-11-22 |
아사히 가세이 파마 가부시키가이샤 |
질소 함유 이환성 복소환 화합물
|
|
CN101429191B
(zh)
|
2008-11-03 |
2012-05-23 |
中国药科大学 |
取代的四氢异喹啉衍生物的用途
|
|
KR20120114355A
(ko)
|
2010-01-13 |
2012-10-16 |
글락소스미스클라인 엘엘씨 |
화합물 및 방법
|
|
EP2566477B1
(en)
|
2010-05-07 |
2015-09-02 |
GlaxoSmithKline Intellectual Property Development Limited |
Amino-quinolines as kinase inhibitors
|
|
JP5864546B2
(ja)
|
2010-05-07 |
2016-02-17 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ |
インダゾール
|
|
US8697739B2
(en)
|
2010-07-29 |
2014-04-15 |
Novartis Ag |
Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof
|
|
JP2013537210A
(ja)
|
2010-09-16 |
2013-09-30 |
ノバルティス アーゲー |
１７α−ヒドロキシラーゼ／Ｃ１７，２０−リアーゼ阻害剤
|
|
EA026115B1
(ru)
|
2010-12-17 |
2017-03-31 |
Ф. Хоффманн-Ля Рош Аг |
Замещенные 6,6-конденсированные азотсодержащие гетероциклические соединения и их применение
|
|
EP2471363A1
(de)
|
2010-12-30 |
2012-07-04 |
Bayer CropScience AG |
Verwendung von Aryl-, Heteroaryl- und Benzylsulfonamidocarbonsäuren, -carbonsäureestern, -carbonsäureamiden und -carbonitrilen oder deren Salze zur Steigerung der Stresstoleranz in Pflanzen
|
|
JP2014515368A
(ja)
|
2011-05-26 |
2014-06-30 |
第一三共株式会社 |
プロテインキナーゼ阻害剤としての複素環化合物
|
|
WO2013027168A1
(en)
|
2011-08-22 |
2013-02-28 |
Pfizer Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
WO2013067300A1
(en)
|
2011-11-04 |
2013-05-10 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Method of treatment
|
|
WO2014026327A1
(en)
|
2012-08-15 |
2014-02-20 |
Merck Sharp & Dohme Corp. |
4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
|
|
BR112015015584A2
(pt)
|
2012-12-27 |
2017-12-12 |
Baruch S Blumberg Inst |
novos agentes antivirais contra infecção por hbv
|
|
US9951027B2
(en)
|
2014-02-11 |
2018-04-24 |
Bayer Pharma Aktiengesellschaft |
Benzimidazol-2-amines as MIDH1 inhibitors
|
|
MX382781B
(es)
|
2014-04-02 |
2025-03-13 |
Intermune Inc |
Piridinonas anti-fibroticas.
|
|
MA41140A
(fr)
|
2014-12-12 |
2017-10-17 |
Cancer Research Tech Ltd |
Dérivés de 2,4-dioxo-quinazoline-6-sulfonamide en tant qu'inhibiteurs de la parg
|
|
MA41179A
(fr)
|
2014-12-19 |
2017-10-24 |
Cancer Research Tech Ltd |
Composés inhibiteurs de parg
|
|
AU2017360939B2
(en)
|
2016-11-18 |
2022-03-03 |
Merck Sharp & Dohme Corp. |
Indazole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
|
|
US12491188B2
(en)
|
2019-03-29 |
2025-12-09 |
Board Of Regents, The University Of Texas System |
Small molecule PARG inhibitors and methods of use thereof
|
|
JP2022548690A
(ja)
|
2019-09-20 |
2022-11-21 |
アイディアヤ バイオサイエンシーズ，インコーポレイティド |
Ｐａｒｇ阻害剤としての４－置換インドールおよびインダゾールスルホンアミド誘導体
|
|
CA3225500A1
(en)
|
2021-10-04 |
2023-04-13 |
Ulrich Luecking |
Parg inhibitory compounds
|
|
US20250002491A1
(en)
|
2021-10-04 |
2025-01-02 |
Forx Therapeutics Ag |
N,n-dimethyl-4-(7-(n-(1-methylcyclopropyl)sulfamoyl)-imidazo[1,5-a]pyridin-5-yl)piperazine-1-carboxamide derivatives and the corresponding pyrazolo[1,5-a]pyridine derivatives as parg inhibitors for the treatment of cancer
|
|
EP4479387A1
(en)
|
2022-02-14 |
2024-12-25 |
ARase Therapeutics Inc. |
Inhibitors of parg
|
|
US20230272485A1
(en)
|
2022-02-16 |
2023-08-31 |
Boundless Bio, Inc. |
Replication stress pathway agent compositions and methods for treating cancer
|
|
MX2024011545A
(es)
|
2022-03-23 |
2024-09-26 |
Ideaya Biosciences Inc |
Compuestos de indazol sustituidos con piperazina como inhibidores de parg.
|
|
TWI878939B
(zh)
|
2022-06-29 |
2025-04-01 |
大陸商杭州聖域生物醫藥科技有限公司 |
五元並六元含氮化物、其中間體、製備方法和應用
|
|
KR20250073643A
(ko)
|
2022-10-03 |
2025-05-27 |
포알엑스 테라퓨틱스 아게 |
Parg 억제 화합물
|
|
EP4646208A1
(en)
|
2023-01-06 |
2025-11-12 |
Ideaya Biosciences, Inc. |
Treatment of er+ breast cancer comprising homologous recombination deficiency using parg inhibitor
|
|
WO2024173453A1
(en)
|
2023-02-14 |
2024-08-22 |
Ideaya Biosciences, Inc. |
Heteroaryl-substituted imidazopyridine compounds
|
|
WO2024173514A1
(en)
|
2023-02-14 |
2024-08-22 |
Ideaya Biosciences, Inc. |
Amide and ester-substituted imidazopyridine compounds
|
|
WO2024173530A1
(en)
|
2023-02-14 |
2024-08-22 |
Ideaya Biosciences, Inc. |
Heteroaryl-substituted pyrazolo/imidazo pyridine compounds
|
|
WO2024173524A1
(en)
|
2023-02-14 |
2024-08-22 |
Ideaya Biosciences, Inc. |
Heteroaryl-substituted benzimidazole compounds
|